Daicel Corporation (TSE:4202) acquired Arbor Biosciences on January 10, 2019. Arbor Biosciences will continue to operate at its current location in Ann Arbor, MI as a wholly owned subsidiary of Daicel Corporation and managed by Chiral Technologies, Inc, a subsidiary of Daicel Corporation. The entire Arbor Biosciences team will remain in place, including co-founders Gulari and Rouillard. DCS Advisory LLC acted as financial advisor to Daicel Corporation. Daicel Corporation (TSE:4202) completed the acquisition of Arbor Biosciences on January 10, 2019.